BURWIG SUSAN E
Exec. VP, Operations
BURWIG SUSAN E has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, BURWIG SUSAN E is listed as Exec. VP, Operations at Medpace Holdings, Inc. Inside the rolling window, BURWIG SUSAN E reported no open-market purchases and 4 open-market sales totaling $28.8M in MEDP. The largest disclosed transaction in the window is a sale of 20,000 MEDP shares on Nov 24, 2025, worth $12.2M.
Companies traded
Other insiders at MEDP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$28.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | MEDP | Sale | $4.8M |
Frequently asked questions
How many SEC Form 4 filings has BURWIG SUSAN E made?
BURWIG SUSAN E has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does BURWIG SUSAN E trade?
BURWIG SUSAN E has filed SEC Form 4 disclosures for 1 company, including MEDP.
When was BURWIG SUSAN E's most recent SEC Form 4 filing?
BURWIG SUSAN E's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is BURWIG SUSAN E's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BURWIG SUSAN E is listed as Exec. VP, Operations.
What is BURWIG SUSAN E's total buy and sell value in the current window?
Inside the rolling retention window, BURWIG SUSAN E bought $0 and sold $28.8M based on SEC Form 4 filings.
What was BURWIG SUSAN E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 MEDP shares on 2025-11-24, worth $12.2M, per SEC Form 4 filings.